Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$110.00

2.06 (1.91%)

06:31
10/23/19
10/23
06:31
10/23/19
06:31

Eli Lilly raises FY19 EPS view to $5.75-$5.85 from $5.67-$5.77, consensus $5.72

Backs FY19 revenue view $22B-$22.5B, consensus $22.23B.

  • 23

    Oct

  • 28

    Oct

LLY Eli Lilly
$110.00

2.06 (1.91%)

09/05/19
09/05/19
UPGRADE
Target $107

Outperform
Incyte upgraded to Outperform from Market Perform at JMP Securities
As previously reported, JMP Securities analyst Reni Benjamin assumed coverage of Incyte (INCY) with an upgraded rating of Outperform and a $107 price target. The analyst cites the "solid fundamentals" of the company's multi-billion dollar Jakafi franchise, including its recent approval in steroid refractory acute graft-versus-host disease, which he believes remains under-appreciated by investors. Benjamin is also positive on Incyte's "marquee" partners that include Novartis (NVS) and Eli Lilly (LLY), along with its $1.7B cash position, diverse pipeline, and strong fundamentals.
09/09/19
PIPR
09/09/19
NO CHANGE
Target $85
PIPR
Neutral
Lilly's 'impressive update' raised bar higher for Blueprint, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said he thinks Eli Lilly (LLY) issued an "impressive update" on selpercatinib at the World Lung meeting, raising the bar for Blueprint Medicines' (BPMC) pralsetinib "meaningfully higher." While selpercatinib's "best-in-class" ORR was maintained, initial durability data could be upwards of 50% better than that of pralsetinib, according to Raymond. While cautioning that his comparison is highly preliminary, Raymond said he worries that LOXO-292's superiority gap against pralsetinib "may be widening." He keeps a Neutral rating on Blueprint shares, which are down about 3% in morning trading to $75.89.
09/25/19
PIPR
09/25/19
NO CHANGE
Target $81
PIPR
Overweight
AbbVie survey supports above-consensus estimates, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on AbbVie (ABBV) shares with an $81 price target following a new rheumatologist survey by his firm's partners Spherix Global Insights. The survey indicates "robust" expectations for the company's oral JAK1 inhibitor Rinvoq, Raymond tells investors in a research note. Rheumatologists project that in six months, Rinvoq will leapfrog Eli Lilly's (LLY) Olumiant to become the second-most prescribed JAK with 5% share, says the analyst, citing the survey. He believes this supports his above-consensus Rinvoq revenue estimates.
10/16/19
BOFA
10/16/19
INITIATION
Target $133
BOFA
Buy
Eli Lilly reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Geoff Meacham reinstated coverage of Eli Lilly with a Buy rating and $133 price target. The analyst sees the company's "high quality, differentiated growth and modest expectations for added pipeline value" as compelling.

TODAY'S FREE FLY STORIES

CLDR

Cloudera

$8.79

0.25 (2.93%)

12:55
11/15/19
11/15
12:55
11/15/19
12:55
Options
Cloudera put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

RHHBY

Roche

$0.00

(0.00%)

12:52
11/15/19
11/15
12:52
11/15/19
12:52
Hot Stocks
Roche to acquire Promedior in up to $1.4B deal »

Earlier, Promedior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

12:50
11/15/19
11/15
12:50
11/15/19
12:50
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.58

-0.89 (-1.96%)

12:49
11/15/19
11/15
12:49
11/15/19
12:49
Hot Stocks
Hulu + Live TV price to increase to $54.99 per month from $44.99 per month »

Hulu announced that it is…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.58

-0.89 (-1.96%)

DIS

Disney

$145.45

-1.74 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

12:45
11/15/19
11/15
12:45
11/15/19
12:45
General news
Breaking General news story  »

Week of 11/15…

BA

Boeing

$371.03

3.73 (1.02%)

, UAL

United Airlines

$92.97

0.43 (0.46%)

12:41
11/15/19
11/15
12:41
11/15/19
12:41
Hot Stocks
United Airlines pulls 737 Max jets off schedule until March 4 »

United Airlines (UAL) is…

BA

Boeing

$371.03

3.73 (1.02%)

UAL

United Airlines

$92.97

0.43 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$4.50

-0.38 (-7.79%)

12:38
11/15/19
11/15
12:38
11/15/19
12:38
Hot Stocks
Empery Asset Management reports 7.17% passive stake in Applied DNA Sciences »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
11/15/19
11/15
12:35
11/15/19
12:35
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

TSLA

Tesla

$349.70

0.19 (0.05%)

, VWAGY

Volkswagen

$0.00

(0.00%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Periodicals
VW CEO says company has no plans to cooperate with Tesla, Reuters reports »

Volkswagen (VWAGY) CEO…

TSLA

Tesla

$349.70

0.19 (0.05%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$5.17

0.03 (0.58%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

, AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

12:23
11/15/19
11/15
12:23
11/15/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been higher…

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

MSFT

Microsoft

$149.59

1.53 (1.03%)

UAA

Under Armour

$17.82

0.69 (4.03%)

UA

Under Armour

$16.04

0.48 (3.08%)

AMRN

Amarin

$22.89

1.4 (6.51%)

RH

RH

$188.04

12.85 (7.33%)

BRK.A

Berkshire Hathaway

$329,640.00

545 (0.17%)

BRK.B

Berkshire Hathaway

$219.62

0.26 (0.12%)

FTCH

Farfetch

$9.69

2.2 (29.37%)

AMAT

Applied Materials

$62.33

5.44 (9.56%)

ACB

Aurora Cannabis

$3.00

-0.29 (-8.81%)

OXY

Occidental Petroleum

$38.90

1.14 (3.02%)

TORC

resTORbio

$1.16

-6.77 (-85.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 28

    Dec

  • 06

    Jan

TORC

resTORbio

$1.14

-6.79 (-85.62%)

12:21
11/15/19
11/15
12:21
11/15/19
12:21
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

12:18
11/15/19
11/15
12:18
11/15/19
12:18
Periodicals
We Company facing SEC probe into possible rule breaches, Bloomberg says »

We Company's WeWork…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCBP

First Choice Bank

$22.49

-0.01 (-0.04%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
First Choice Bancorp announces resignation of CFO Lynn Hopkins »

First Choice Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$120.92

-0.03 (-0.02%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
AmEx reports October consumer card write-off rate 2.3% vs. 2.0% last month »

American Express reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/15/19
11/15
12:16
11/15/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$219.62

1.07 (0.49%)

12:10
11/15/19
11/15
12:10
11/15/19
12:10
Hot Stocks
Amgen treatment of multiple myeloma granted FDA orphan designation »

Amgen's treatment of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AXGT

Axovant

$4.71

-0.05 (-1.05%)

12:07
11/15/19
11/15
12:07
11/15/19
12:07
Hot Stocks
Axovant granted FDA orphan designation for treatment of GM1 gangliosidosis »

Axovant Sciences was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$43.75

1.85 (4.42%)

, FB

Facebook

$194.64

1.49 (0.77%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Recommendations
Lyft, Facebook, Amazon.com, Netflix, Twitter, IAC analyst commentary  »

JPMorgan adds Lyft to…

LYFT

Lyft

$43.75

1.85 (4.42%)

FB

Facebook

$194.64

1.49 (0.77%)

AMZN

Amazon.com

$1,747.79

-6.92 (-0.39%)

NFLX

Netflix

$293.25

3.57 (1.23%)

TWTR

Twitter

$29.38

0.49 (1.70%)

IAC

IAC

$223.02

2.85 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

  • 06

    Feb

AUPH

Aurinia Pharmaceuticals

$5.37

0.23 (4.47%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
11/15/19
11/15
12:05
11/15/19
12:05
General news
Fed Q4 Nowcasts revised lower. »

Fed Q4 Nowcasts revised…

ENVA

Enova International

$22.15

-1.895 (-7.88%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Enova International falls -8.0% »

Enova International is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANG

Cango

$6.24

-0.6 (-8.77%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Cango falls -8.4% »

Cango is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRA

Contura Energy

$8.50

-0.88 (-9.38%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Contura Energy falls -9.5% »

Contura Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.